Nesher, G, Margalit, R, Ashkenazi, Y J · Seminars in arthritis and rheumatism · 2001 · DOI
This study looked at antibodies (immune proteins) that attack the nuclear envelope, the protective membrane around cell nuclei. Researchers found that different types of these antibodies are associated with different diseases, and preliminary findings suggest they may help diagnose ME/CFS. The study suggests that testing for these antibodies could help doctors identify certain autoimmune conditions.
This research is significant for ME/CFS because it presents preliminary evidence that antilamin antibodies could serve as a diagnostic biomarker for the condition. As ME/CFS lacks objective diagnostic tests, identifying specific autoantibody patterns could help clinicians recognize the disease earlier and more reliably. Understanding immune abnormalities in ME/CFS may also help distinguish it from other autoimmune conditions with overlapping symptoms.
This review does not establish causation between antilamin antibodies and ME/CFS symptoms, only an association. The 'preliminary data' mentioned for ME/CFS are not fully detailed in the abstract, making it unclear how robust or replicated these findings are. The study also does not demonstrate that anti-nuclear envelope antibodies are specific to ME/CFS or explain the biological mechanisms by which these antibodies might contribute to disease pathology.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →